US Bancorp’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,131	Closed	-$110K	–	3735
2015 Q1	$110K	Sell	1,131 -68	-6%	-$6.61K	﹤0.01%	2117
2014 Q4	$112K	Buy	1,199 +262	+28%	+$24.5K	﹤0.01%	2077
2014 Q3	$65K	Buy	937 +66	+8%	+$4.58K	﹤0.01%	2357
2014 Q2	$91K	Buy	+871	New	+$91K	﹤0.01%	2179